|
89 Companies |
|
65 Products |
|
65 Products |
|
50 Mechanisms of Action |
|
830 Trials |
|
63778 News |
|
| «12...679680681682683684685686687688689...712713» |
- | Simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension) / Novartis
Trial completion: Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy (clinicaltrials.gov) - Jul 11, 2017
P4, N=79, Completed, Sponsor: University Hospital of Patras
Recruiting --> Completed
- New trial: Clinical Investigation of the eyeWatch Glaucoma Drainage Device (clinicaltrials.gov) - Jul 7, 2017
P=N/A, N=30, Not yet recruiting, Sponsor: Rheon Medical SA
- |||| Durysta (bimatoprost implant) / AbbVie
Trial primary completion date: Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension (clinicaltrials.gov) - Jul 6, 2017
P3, N=600, Recruiting, Sponsor: Allergan
Recruiting --> Completed Trial primary completion date: Feb 2018 --> Apr 2019
- | Enrollment open, Trial initiation date, Surgery: Prevalence of Corneal Astigmatism Before Glaucoma Surgery in Chinese Patients With Primary Angle-closure Glaucoma (clinicaltrials.gov) - Jul 6, 2017
P=N/A, N=1200, Recruiting, Sponsor: Mingkai Lin
Trial primary completion date: Feb 2018 --> Apr 2019 Not yet recruiting --> Recruiting | Initiation date: Jun 2017 --> Jan 2017
- | Enrollment open: The PUPIL Study - Automated, Quantitative Pupil Assessment Using Binocular OCT (clinicaltrials.gov) - Jul 6, 2017
P=N/A, N=100, Recruiting, Sponsor: University College, London
Not yet recruiting --> Recruiting | Initiation date: Jun 2017 --> Jan 2017 Not yet recruiting --> Recruiting
- | Enrollment open: Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma (clinicaltrials.gov) - Jul 4, 2017
P=N/A, N=50, Recruiting, Sponsor: Centre hospitalier de l'Universit
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | Augentropfen Stulln Mono (digitalisglycosides/escuilin) / China Medical System, Zioptan (tafluprost) / Santen, Merck (MSD)
New P4 trial: A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness (clinicaltrials.gov) - Jul 2, 2017
P4, N=30, Recruiting, Sponsor: Ordination Dr. Hommer
- || mitomycin / Generic mfg.
Trial completion, Surgery: Oculusgen (Ologen) Glaucoma MMC Control in Estonia (clinicaltrials.gov) - Jun 27, 2017
P3, N=20, Completed, Sponsor: Pro Top & Mediking Company Limited
Not yet recruiting --> Recruiting Recruiting --> Completed
- || Trial completion: Ologen (OculusGen)-Glaucoma Case Control Trial in India (clinicaltrials.gov) - Jun 27, 2017
P3, N=40, Completed, Sponsor: Pro Top & Mediking Company Limited
Recruiting --> Completed Recruiting --> Completed
- | Trial primary completion date: GLAUS: Evaluation of the Possibility to Delegate Glaucoma Surveillance to Orthoptists in Hospital (clinicaltrials.gov) - Jun 22, 2017
P=N/A, N=160, Recruiting, Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Recruiting --> Completed Trial primary completion date: Apr 2017 --> Apr 2020
- | Enrollment open: Glaucoma Management in the African-Derived Developing World Using Trabeculoplasty (clinicaltrials.gov) - Jun 21, 2017
P=N/A, N=129, Enrolling by invitation, Sponsor: West Virginia University
Trial primary completion date: Apr 2017 --> Apr 2020 Active, not recruiting --> Enrolling by invitation
- | Trial initiation date: Automatic vs. Manual Optic Disc Planimetry (clinicaltrials.gov) - Jun 20, 2017
P=N/A, N=152, Not yet recruiting, Sponsor: University of Zurich
Active, not recruiting --> Enrolling by invitation Initiation date: Nov 2016 --> Jul 2017
- | Trial completion, Trial primary completion date: Incidence of Dyschromatopsia in Glaucoma (clinicaltrials.gov) - Jun 20, 2017
P=N/A, N=100, Completed, Sponsor: University of Zurich
Initiation date: Nov 2016 --> Jul 2017 Not yet recruiting --> Completed | Trial primary completion date: Dec 2016 --> May 2017
- ||| Trial completion: Evaluation of the Repeatability and Reproducibility of AngioVue (clinicaltrials.gov) - Jun 20, 2017
P=N/A, N=70, Completed, Sponsor: Optovue
Not yet recruiting --> Completed | Trial primary completion date: Dec 2016 --> May 2017 Enrolling by invitation --> Completed
- | Simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension) / Novartis
New P4 trial: Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy (clinicaltrials.gov) - Jun 20, 2017
P4, N=70, Recruiting, Sponsor: University Hospital of Patras
- |||||||||| PRO-122 / Sophia Laboratories
New P3 trial, Head-to-Head: PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM) (clinicaltrials.gov) - Jun 20, 2017
P3, N=51, Not yet recruiting, Sponsor: Laboratorios Sophia S.A de C.V.
- | New trial: Comparison of SITA-Standard Compared to SITA-Fast Visual Fields. (clinicaltrials.gov) - Jun 19, 2017
P=N/A, N=150, Not yet recruiting, Sponsor: Royal Devon and Exeter NHS Foundation Trust
- | New trial: Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma (clinicaltrials.gov) - Jun 15, 2017
P=N/A, N=50, Not yet recruiting, Sponsor: Centre hospitalier de l'Universit
- | New trial: Comparison of Superior vs Nasal/Temporal Laser Peripheral Iridotomy in Primary Angle Closure (clinicaltrials.gov) - Jun 15, 2017
P=N/A, N=1000, Completed, Sponsor: Venkatesh Rengaraj
- | New trial: A Study Using Transorbital Alternating Current Stimulation for People With Glaucoma (clinicaltrials.gov) - Jun 15, 2017
P=N/A, N=20, Not yet recruiting, Sponsor: New York University School of Medicine
- Trial primary completion date, Surgery: Measurement of Ocular Tensional Fluctuation by Triggerfish Lens Before and After Cataract Surgery in Patients With Exfoliative Glaucoma (clinicaltrials.gov) - Jun 14, 2017
P=N/A, N=10, Recruiting, Sponsor: University Hospital, Brest
Enrolling by invitation --> Completed Trial primary completion date: Sep 2017 --> Sep 2018
- | Trial primary completion date: Analysis of Translaminar Pressure Gradient Using Noninvasive Cerebrospinal Fluid Pressure Monitoring (clinicaltrials.gov) - Jun 14, 2017
P=N/A, N=200, Enrolling by invitation, Sponsor: University of Miami
Trial primary completion date: Sep 2017 --> Sep 2018 Trial primary completion date: Dec 2017 --> Dec 2018
- | Trial initiation date: Collision Warning Device for Blind and Visually Impaired (clinicaltrials.gov) - Jun 14, 2017
P=N/A, N=90, Not yet recruiting, Sponsor: Massachusetts Eye and Ear Infirmary
Trial primary completion date: Dec 2017 --> Dec 2018 Initiation date: May 2017 --> Aug 2017
- |||| trabodenoson/latanoprost / Rocket Pharma, trabodenoson (INO-8875) / Rocket Pharma
Trial completion: Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG (clinicaltrials.gov) - Jun 7, 2017
P2, N=201, Completed, Sponsor: Inotek Pharmaceuticals Corporation
Initiation date: May 2017 --> Aug 2017 Active, not recruiting --> Completed
- ||| Trial completion, Phase classification: AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma (clinicaltrials.gov) - Jun 1, 2017
P=N/A, N=65, Completed, Sponsor: AqueSys, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: P3 --> PN/A
- | New P3 trial: PROTECT: Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated with Proton Therapy for a Large Choroidal Melanoma (clinicaltrials.gov) - May 31, 2017
P3, N=56, Not yet recruiting, Sponsor: Centre Hospitalier Universitaire de Nice
- ||| TAK-639 / Takeda
Enrollment open: Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma (clinicaltrials.gov) - May 26, 2017
P1, N=120, Recruiting, Sponsor: Shire
Active, not recruiting --> Completed | Phase classification: P3 --> PN/A Not yet recruiting --> Recruiting
- || Eylea (aflibercept intravitreal) / Bayer, Regeneron
Enrollment change: RETRO CRVO: Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion (clinicaltrials.gov) - May 25, 2017
P=N/A, N=122, Active, not recruiting, Sponsor: Bayer
Not yet recruiting --> Recruiting N=48 --> 122
- | New trial: Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma. (clinicaltrials.gov) - May 25, 2017
P=N/A, N=15, Completed, Sponsor: Federal University of Minas Gerais
- | New trial: Effect of SLT Location on Treatment Outcomes (clinicaltrials.gov) - May 24, 2017
P=N/A, N=84, Recruiting, Sponsor: St. Joseph's Healthcare Hamilton
- | latanoprost / Generic mfg.
Trial primary completion date: Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT (clinicaltrials.gov) - May 22, 2017
P4, N=70, Recruiting, Sponsor: Medical University of Vienna
N=48 --> 122 Trial primary completion date: Apr 2017 --> Sep 2017
- | Trial primary completion date: Blood Flow Regulation in Glaucoma (clinicaltrials.gov) - May 22, 2017
P=N/A, N=120, Recruiting, Sponsor: Medical University of Vienna
Trial primary completion date: Apr 2017 --> Sep 2017 Trial primary completion date: Mar 2017 --> Sep 2017
- | New trial, Surgery: Prevalence of Corneal Astigmatism Before Glaucoma Surgery in Chinese Patients With Primary Angle-closure Glaucoma (clinicaltrials.gov) - May 18, 2017
P=N/A, N=1200, Not yet recruiting, Sponsor: Mingkai Lin
- | New trial: Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy (clinicaltrials.gov) - May 18, 2017
P=N/A, N=20, Not yet recruiting, Sponsor: Germans Trias i Pujol Hospital
- | New trial: The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program (clinicaltrials.gov) - May 18, 2017
P=N/A, N=57, Recruiting, Sponsor: University of Michigan
- | New trial, Adherence: GOAL: Glaucoma Management Optimism for African Americans Living With Glaucoma (clinicaltrials.gov) - May 18, 2017
P=N/A, N=240, Not yet recruiting, Sponsor: University of Alabama at Birmingham
- | Lumitin (conbercept) / Chengdu Kanghong Pharma
New trial: The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma (clinicaltrials.gov) - May 15, 2017
P=N/A, N=30, Recruiting, Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University
- Enrollment change, Trial initiation date: DUETTE: Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy (clinicaltrials.gov) - May 15, 2017
P=N/A, N=48, Completed, Sponsor: Transcend Medical, Inc.
Trial primary completion date: Mar 2017 --> Sep 2017 N=65 --> 48 | Initiation date: Jun 2010 --> Feb 2010
- | New trial, Surgery: Longitudinal Study on Glaucoma Surgery Using XEN (clinicaltrials.gov) - May 11, 2017
P=N/A, N=150, Active, not recruiting, Sponsor: Swiss Vision Network
- ||||| Simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension) / Novartis
New P4 trial: Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma (clinicaltrials.gov) - May 11, 2017
P4, N=200, Not yet recruiting, Sponsor: Novartis Pharmaceuticals
- | Phase classification: The American Glaucoma Society (AGS) Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS) (clinicaltrials.gov) - May 10, 2017
P=N/A, N=280, Enrolling by invitation, Sponsor: Robert Feldman
N=65 --> 48 | Initiation date: Jun 2010 --> Feb 2010 Phase classification: P4 --> P=N/A
- | New trial: PAIR2: PAIR Study-PAP And IOP Relationship: Study 2 (clinicaltrials.gov) - May 9, 2017
P=N/A, N=30, Recruiting, Sponsor: Papworth Hospital NHS Foundation Trust
- | latanoprost / Generic mfg.
Biomarker, Trial completion, Phase classification, Trial primary completion date: Glaucoma Biomarkers (clinicaltrials.gov) - May 4, 2017
P4, N=136, Completed, Sponsor: University of Michigan
Phase classification: P4 --> P=N/A Active, not recruiting --> Completed | Phase classification: PN/A --> P4 | Trial primary completion date: Dec 2016 --> Aug 2016
- | Enrollment open: Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma (clinicaltrials.gov) - May 4, 2017
P=N/A, N=290, Recruiting, Sponsor: St. Jude Children's Research Hospital
Active, not recruiting --> Completed | Phase classification: PN/A --> P4 | Trial primary completion date: Dec 2016 --> Aug 2016 Not yet recruiting --> Recruiting
- Eylea (aflibercept intravitreal) / Bayer, Regeneron
Enrollment closed: RETRO CRVO: Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion (clinicaltrials.gov) - May 3, 2017
P=N/A, N=48, Active, not recruiting, Sponsor: Bayer
Not yet recruiting --> Recruiting Completed --> Active, not recruiting
- || Enrollment closed, Trial primary completion date: Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study (clinicaltrials.gov) - May 3, 2017
P=N/A, N=375, Active, not recruiting, Sponsor: Wills Eye
Completed --> Active, not recruiting Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Jun 2018
- | Trial completion, Trial primary completion date: Pressure Difference Between Brain and Eye: a Possible Cause to Normal Tension Glaucoma. (clinicaltrials.gov) - May 3, 2017
P=N/A, N=17, Completed, Sponsor: Ume
Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Jun 2018 Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jun 2016
- | New trial, Surgery: An Innovation in Glaucoma Surgery: XEN45 Gel Stent Implantation (clinicaltrials.gov) - May 3, 2017
P=N/A, N=15, Completed, Sponsor: Trakya University
- | Trial completion, Adherence: SIGMA: Study on Incentives for Glaucoma Medications Adherence (clinicaltrials.gov) - May 1, 2017
P=N/A, N=100, Completed, Sponsor: Duke-NUS Graduate Medical School
Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jun 2016 Active, not recruiting --> Completed
- | Eylea (aflibercept intravitreal) / Bayer, Regeneron
Trial completion: RETRO CRVO: Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion (clinicaltrials.gov) - May 1, 2017
P=N/A, N=48, Completed, Sponsor: Bayer
Active, not recruiting --> Completed Recruiting --> Completed